When Richard Paddock, MD, noticed his PSA rising, he knew something wasn't right. As a urologist with more than 40 years of experience, he understood the warning signs of prostate cancer recurrence. The challenge was that multiple imaging studies couldn't find where the cancer had returned.
Oliver Sartor, MD, director of the Transformational Prostate Cancer Research Center at East Jefferson General Hospital Cancer Center and affiliated with Tulane University School of Medicine, enrolled Dr. Paddock as the second patient in an innovative clinical imaging study using the next-generation radiopharmaceutical SAR-bisPSMA paired with Copper-64 (Cu-64) for PSMA PET imaging.
That discovery allowed East Jefferson General Hospital radiation oncologist Kendra Harris, MD, affiliated with Tulane University, to deliver targeted radiation therapy directly to the lesion.
Today, Dr. Paddock's PSA has dropped dramatically, providing encouraging evidence that the treatment was successful. His story highlights the importance of prostate cancer screening, ongoing monitoring, and access to advanced diagnostic tools when conventional approaches fall short.
As both a physician and patient, Dr. Paddock hopes his experience encourages other men to pay attention to their PSA levels and seek evaluation when changes occur.
Read how innovative imaging and expert care at East Jefferson General Hospital helped uncover what other scans couldn't find and opened the door to effective treatment.
go.lcmchealth.org/utcbW